Supported Research
Design and Production of a Clinical Grade Retroviral Vector for a Phase I Clinical Study to Investigate Replacement Gene Therapy for the Treatment of Fanconi Anemia.
Amount Funded: $61,000
Researchers: Hans-Peter Kiem , Peter Kurre